載入...
FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitors
-like tyrosine kinase-3 (FLT3) is a receptor tyrosine kinase that normally functions in hematopoietic cell survival, proliferation and differentiation. Constitutively activating mutations of FLT3 map predominately to the juxtamembrane domain (internal tandem duplications; ITD) or the activation loop...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5355235/ https://ncbi.nlm.nih.gov/pubmed/28077790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14539 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|